Dr. Craig Laferrière is an accomplished medical advisor with expertise in vaccine design and manufacturing, with over 25 years of experience in the areas of regulatory, clinical research, access and marketing. Prior to his role as Head Vaccine Development at Novateur, Dr. Laferrière was the Medical Advisor Vaccines at Pfizer Canada, as a part of the Vaccine Leadership Team. Previously, he worked in preclinical and clinical research as the manager of analytical and clinical serology team at GlaxoSmithKline in Belgium and Canada. Throughout his career, Dr. Laferrière was a consultant to Biovac in South Africa and he optimized the design of a Hib conjugate vaccine. Dr. Laferrière is bilingual in English/French and he holds a PhD in Synthetic Organic Chemistry from the University of Ottawa.